clopidogrel bisulfate
information and resources from the National Cancer Institute
NCI Thesaurus | clopidogrel bisulfate
A thienopyridine with antiplatelet activity. Clopidogrel bisulfate irreversibly alters the platelet receptor for adenosine diphosphate (ADP), thereby blocking the binding of ADP to its receptor, inhibiting ADP-mediated activation of the glycoprotein complex GPIIb/IIIa, and inhibiting fibrinogen binding to platelets and platelet adhesion and aggregation. NCI Thesaurus | clopidogrel bisulfate
A thienopyridine with antiplatelet activity. Clopidogrel bisulfate irreversibly alters the platelet receptor for adenosine diphosphate (ADP), thereby blocking the binding of ADP to its receptor, inhibiting ADP-mediated activation of the glycoprotein complex GPIIb/IIIa, and inhibiting fibrinogen binding to platelets and platelet adhesion and aggregation.
|
|
|
|
news articles
Sanofi-aventis And BMS Announce Agreement To Settle US Plavix® ... Mar 25, 2006
Medical News Today (press release), The lawsuit relates to the validity of a composition of matter patent for clopidogrel bisulfate (the '265 patent), a medicine made available in the United ...
Apotex Announces Agreement to Settle US PLAVIX Litigation; Apotex ... Mar 22, 2006
PharmaLive.com (press release), The lawsuit relates to the validity of a patent for clopidogrel bisulfate (the '265 patent) sold in the United States as PLAVIX(R). The trial scheduled to ...
FIRST-EVER GUIDELINES ISSUED FOR MANAGEMENT OF SERIOUS BUT UNDER ... Mar 24, 2006
PR Newswire (press release), The guidelines define appropriate therapies including the use of anti-platelet medicines such as Plavix(R) (clopidogrel bisulfate), which can help reduce the ...
Sanofi-Aventis, Bristol-Myers Squibb Reach Agreement To Settle US ... Mar 21, 2006
Trading Markets, The lawsuit is related to the validity of a composition of matter patent for clopidogrel bisulfate, a medicine made available in US by sanofi-aventis and ...
Sanofi And Bristol Reveal Proposed Agreement With Apotex To Settle ... Mar 21, 2006
Trading Markets, The lawsuit has been filed in a US District Court, regarding the validity of a composition of matter patent for clopidogrel bisulfate, earlier made available ...
Sanofi-Aventis/Apotex: Olive Branch Acceptance to Reduce Generic ... Mar 23, 2006
Black Enterprise, ...expires in 2011. Apotex had questioned the validity of a composition of matter patent for clopidogrel bisulfate. Should another ...
Role Of Dual Antiplatelet Therapy In Prevention Of ... Mar 18, 2006
Medical News Today (press release), Clopidogrel bisulfate is a prescription antiplatelet medicine taken once a day that helps keep platelets in the blood from sticking together and forming clots. ...
Sanofi, BMS Settle Patent Suit With Apotex Mar 21, 2006
International News Service, ...the settlement deal, Sanofi-aventis will grant to Apotex a royalty-bearing license to make and sell cholesterol drug Plavix (clopidogrel bisulfate) in the ...
UPDATE 2-Sanofi, Bristol say settle Plavix patent suit Mar 21, 2006
Reuters Under terms of the proposed Apotex settlement, Sanofi-Aventis would grant Apotex a royalty-bearing license to sell clopidogrel bisulfate in the United States ...
Sanofi, Bristol to Settle Apotex Lawsuit Mar 21, 2006
MSN Money ...attack or stroke. Apotex makes a generic version of the drug using the same key ingredient, clopidogrel bisulfate. Under the terms ...
Sanofi, Bristol to Settle Plavix Patent Suit Mar 22, 2006
Los Angeles Times, Under terms of the proposed Apotex settlement, Sanofi-Aventis would grant Apotex a royalty-bearing license to sell clopidogrel bisulfate in the US once the ...
Bristol-Myers, Sanofi-Aventis reach Plavix deal Mar 21, 2006
MarketWatch The trial date is now suspended, pending a finalization of the settlement. Plavix is known generically as clopidogrel bisulfate. ...
Sanofi, Bristol Myers Settle Apotex Suit Over Plavix (Update4) Mar 21, 2006
Bloomberg Under the terms of the agreement, Apotex can sell its version at least eight months before the expiration of a patent on clopidogrel bisulfate, the main ...
Drug Makers Reach Accord in Patent Case Over Plavix Mar 21, 2006
New York Times, Dr. Reddy's in 2002 after they each filed an application with the Food and Drug Administration to market generic Plavix, known as clopidogrel bisulfate, in the ...
Drug makers reach patent accord over Plavix Mar 22, 2006
International Herald Tribune, ...in 2002 after they both filed applications with the Food and Drug Administration to market a generic form of Plavix, known as clopidogrel bisulfate, in the ...
MNCs seek deal with Dr. Reddy's for Plavix Mar 22, 2006
Business Standard, DRL had filed an abbreviated new drug application (ANDA) for its own molecule of Clopidogrel Bisulfate, which is the chemical name for Plavix, with the US Food ...
Plavix Patent Suit Settled Mar 22, 2006
Red Herring, A federal court trial over the patent for the drug, also known as clopidogrel bisulfate, had been scheduled to begin during June 2006 in New York , but the ...
Health index stays firm as Sensex tanks Mar 22, 2006
Business Standard, Under terms of the proposed settlement Sanofi-Aventis would grant Apotex a royalty bearing licence to market clopidogrel bisulfate, a chemical name for Plavix ...
First-Ever Guidelines Issued for Management of Serious but Under ... Mar 24, 2006
Yahoo! News (press release) The guidelines define appropriate therapies including the use of anti-platelet medicines such as Plavix® (clopidogrel bisulfate), which can help reduce the ...
Sanofi, Bristol Settle Apotex Lawsuit Over Plavix (Update2) Mar 21, 2006
Bloomberg Apotex can sell its version at least eight months before the expiration of a patent on clopidogrel bisulfate, the main compound for the drug. ...
Bristol, Sanofi stock surges on Plavix deal Mar 22, 2006
CNNMoney.com As part of the deal, Apotex is granted a royalty-bearing license to sell clopidogrel bisulfate, the active ingredient in Plavix, in the US after that date of ...
PLAVIX(R) (clopidogrel bisulfate) Recommended as Effective ... Dec 13, 2005
PR Newswire (press release), Americans at an increased risk for a heart attack or stroke(1). In the guidelines, the antiplatelet therapy Plavix(R) (clopidogrel bisulfate) is recommended ...
PLAVIX(R) (clopidogrel bisulfate) Recommended as Effective ... Dec 13, 2005
Yahoo! News (press release) Americans at an increased risk for a heart attack or stroke(1). In the guidelines, the antiplatelet therapy Plavix® (clopidogrel bisulfate) is recommended for ...
(PRN) - Michigan Attorney General Cox Announces Six Arrests in ... Dec 13, 2005
Bolsamania.com, ...[+]. (PRN) - Midwest Airlines Introduces New Lower-Priced Excursion Fares ... [+. PRN) - PLAVIX(R) (clopidogrel bisulfate) Recommended as Effective ...
|
|
